Genomic Determinants of Antimicrobial Resistance: Integrating Molecular Mechanisms, Diagnostic Technologies, and Artificial Intelligence for Precision Treatment

Antimicrobial resistance (AMR) remains a major global health challenge, complicating infection management and increasing the risk of treatment failure. Although conventional antimicrobial susceptibility testing guides treatment selection, delays in obtaining results can hinder timely targeted therapy. Advances in bacterial genomics, molecular diagnostics, and artificial intelligence (AI) offer opportunities to improve resistance detection and support precision antimicrobial therapy. However, a persistent gap remains between identifying genomic resistance determinants, translating them into reliable diagnostic interpretations, and applying these findings to individual treatment decisions. This review critically synthesizes evidence on the genomic architecture of AMR, emerging diagnostic technologies, AI-assisted interpretation, and their integration into clinical practice. It examines major resistance mechanisms, including acquired resistance genes, chromosomal mutations, mobile genetic elements, and regulatory changes, alongside whole-genome sequencing, molecular detection, and phenotypic susceptibility testing. It further evaluates machine learning applications in resistance prediction and clinical decision support, highlighting limitations associated with genotype–phenotype discordance, dataset representativeness, model generalisability, diagnostic uncertainty, infrastructure, and clinical validation. Ethical governance, regulatory oversight, and equitable implementation are also considered. An integrative conceptual framework is proposed linking biological determinants, diagnostic evidence, computational interpretation, clinical decision-making, and patient outcomes. The framework emphasizes that genomic detection and AI predictions require contextual interpretation and clinical oversight. Ultimately, translating these innovations into effective precision antimicrobial therapy requires mechanistic understanding, robust validation, clinical integration, sustainable implementation, and demonstrated improvements in patient outcomes.

Authors

Institutions

Publication Details

Journal
Asian Journal of Microbiology and Biotechnology
Published
2026-11-18
DOI
https://doi.org/10.56557/ajmab/2026/v11i211389
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genomic Determinants of Antimicrobial Resistance: Integrating Molecular Mechanisms, Diagnostic Technologies, and Artificial Intelligence for Precision Treatment

Esther Sarpong, Felix Darko, Toheeb Olaniyi Falakin, Victoria Ifeyinwa Uwakwe et al.
2 links
Asian Journal of Microbiology and Biotechnology
Antibiotic Resistance in Bacteria
article

Genomic Determinants of Antimicrobial Resistance: Integrating Molecular Mechanisms, Diagnostic Technologies, and Artificial Intelligence for Precision Treatment

Esther Sarpong, Felix Darko, Toheeb Olaniyi Falakin, Victoria Ifeyinwa Uwakwe, Nana Akua Fosua Lawson Darko, Kwadwo Owusu-Boateng
article en

Abstract

Antimicrobial resistance (AMR) remains a major global health challenge, complicating infection management and increasing the risk of treatment failure. Although conventional antimicrobial susceptibility testing guides treatment selection, delays in obtaining results can hinder timely targeted therapy. Advances in bacterial genomics, molecular diagnostics, and artificial intelligence (AI) offer opportunities to improve resistance detection and support precision antimicrobial therapy. However, a persistent gap remains between identifying genomic resistance determinants, translating them into reliable diagnostic interpretations, and applying these findings to individual treatment decisions. This review critically synthesizes evidence on the genomic architecture of AMR, emerging diagnostic technologies, AI-assisted interpretation, and their integration into clinical practice. It examines major resistance mechanisms, including acquired resistance genes, chromosomal mutations, mobile genetic elements, and regulatory changes, alongside whole-genome sequencing, molecular detection, and phenotypic susceptibility testing. It further evaluates machine learning applications in resistance prediction and clinical decision support, highlighting limitations associated with genotype–phenotype discordance, dataset representativeness, model generalisability, diagnostic uncertainty, infrastructure, and clinical validation. Ethical governance, regulatory oversight, and equitable implementation are also considered. An integrative conceptual framework is proposed linking biological determinants, diagnostic evidence, computational interpretation, clinical decision-making, and patient outcomes. The framework emphasizes that genomic detection and AI predictions require contextual interpretation and clinical oversight. Ultimately, translating these innovations into effective precision antimicrobial therapy requires mechanistic understanding, robust validation, clinical integration, sustainable implementation, and demonstrated improvements in patient outcomes.

Asian Journal of Microbiology and BiotechnologyVol. 11(2)
University of Cape Coast (GH), OU Health (US), University of Oklahoma Health Sciences Center (US), Bemidji State University (US), University for Development Studies (GH), University of Oklahoma (US), Kentucky State University (US)
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon